jjccgroup2021

January 17, 2022

Life Science Regulatory Compliance Firm Delivers Business Success Through Strategic Partnerships

J&JCC Group offers unprecedented success for clients navigating Regulatory Compliance during the COVID-19 Pandemic. Irvine, California, January 12, 2022, J&JCC Group, a leading consulting firm, offers […]
August 15, 2018

FDA Intention to Develop A New Standard for Tobacco Products- Reduced Health Risk!

The Food and Drug Administration (FDA) has recently announced its intention to “explore clear and meaningful measures to make tobacco products less toxic, appealing and addictive. […]
July 28, 2018

Tobacco Products Labeling Compliance. Another Deadline is Approaching – August 10, 2018

Nicotine Addictiveness Warning Statement Beginning August 10, 2018, FDA will enforce a new nicotine warning Statement. Manufacturers and distributors cannot package, sell, offer to sell, distribute, […]
May 17, 2018

FDA requires additional e-cigarette makers to provide critical information so the agency can better examine youth use and product appeal

Summary Letters to four companies follow initial request to JUUL Labs as part of an ongoing effort to address youth use under the agency’s Youth Tobacco […]
June 5, 2016

Current Good Manufacturing Practices — An Overlooked Requirement with Far Reaching Consequences

A significant provision of the Family Smoking Prevention and Tobacco Control Act is the requirement for tobacco manufacturers to operate in compliance with current good manufacturing […]